Bach1-mediated suppression of p53 is inhibited by p19 ARF independently of MDM2

Hironari Nishizawa, Kazushige Ota, Yoshihiro Dohi, Tsuyoshi Ikura, Kazuhiko Igarashi

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Abstract

Cellular senescence prevents the aberrant proliferation of damaged cells. The transcription factor Bach1 binds to p53 to repress cellular senescence, but it is still unclear how the Bach1-p53 interaction is regulated. We found that the Bach1-p53 interaction was inhibited by oncogenic Ras, bleomycin, and hydrogen peroxide. Proteomics analysis of Bach1 complex revealed its interaction with p19 ARF, a tumor suppressor that competitively inhibited the Bach1-p53 interaction when overexpressed within cells. Reduction of MDM2 expression in wild-type murine embryonic fibroblasts (MEFs) did not result in slower proliferation, showing that Bach1 plays a role in keeping the proliferation of MEFs independent of MDM2. Consistent with this interpretation, expression of p21 was highly induced in MEFs when both Bach1 and MDM2 were abrogated. The level of Bach1 protein was reduced on knockdown of p53. These results suggest that p53 activation involves its dissociation from Bach1, achieved in part by the competitive binding of p19 ARF to Bach1. The p19 ARF-Bach1 interaction constitutes a regulatory pathway of p53 in parallel with the p19 ARF-MDM2 pathway.

Original languageEnglish
Pages (from-to)897-903
Number of pages7
JournalCancer science
Volume103
Issue number5
DOIs
Publication statusPublished - 2012 May

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Bach1-mediated suppression of p53 is inhibited by p19 <sup>ARF</sup> independently of MDM2'. Together they form a unique fingerprint.

Cite this